Toward cell-based therapy of type I diabetes

Trends in Immunology
Dieter KabelitzLucienne Chatenoud

Abstract

Type 1 diabetes (T1D) is an autoimmune disease that results from the destruction of insulin-producing pancreatic islet cells owing to the aggressive effector function of autoreactive T cells. In addition to lifetime supply of exogenous insulin, whole-pancreas or islet transplantation is presently the only alternative therapy for severely ill patients. Here, we discuss the current status of the development of cell-based therapies that are based on essentially two options, i.e. replacement of islet cells by islet-like cells derived from embryonic or adult stem cells, and re-establishment of immunological tolerance to islet self-antigens through regulatory T cells and/or tolerance-promoting monocyte-derived cells. A combination of both approaches will be required to turn cell-based therapy of T1D into clinical success.

References

Mar 15, 1977·Cellular Immunology·J R OehlerJ Y Djeu
Aug 1, 1994·Endocrine Reviews·J F Bach
Mar 13, 2001·Annual Review of Immunology·J F Bach, L Chatenoud
Jan 5, 2002·Differentiation; Research in Biological Diversity·B Soria
Sep 20, 2002·The New England Journal of Medicine·Jean-Francois Bach
Jan 15, 2003·Proceedings of the National Academy of Sciences of the United States of America·Przemyslaw BlyszczukAnna M Wobus
Jun 24, 2003·Nature Biotechnology·David HessMickie Bhatia
Nov 15, 2003·Science·Shohta KodamaDenise L Faustman
Jun 9, 2004·The Journal of Experimental Medicine·Qizhi TangJeffrey A Bluestone
Jun 9, 2004·The Journal of Experimental Medicine·Kristin V TarbellRalph M Steinman
Aug 17, 2004·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Dirk Homann, Matthias von Herrath
Oct 7, 2004·European Journal of Immunology·Qizhi TangJeffrey A Bluestone
Oct 16, 2004·Critical Reviews in Immunology·Janneke N Samsom
Oct 16, 2004·Immunity·Ching-Tai HuangDario A A Vignali
Dec 17, 2004·The International Journal of Developmental Biology·Przemyslaw BlyszczukAnna M Wobus
Mar 23, 2005·Immunity·Jason D FontenotAlexander Y Rudensky
Jun 24, 2005·The New England Journal of Medicine·Bart KeymeulenLucienne Chatenoud
Jul 15, 2005·American Journal of Physiology. Gastrointestinal and Liver Physiology·Bernat SoriaFranz Martin
Nov 11, 2005·American Journal of Therapeutics·Theresa AlyGeorge S Eisenbarth
Nov 25, 2005·Diabetes·Mikael KnipHans K Akerblom
Nov 25, 2005·Diabetes·Catherine PihokerAke Lernmark
Mar 1, 2006·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·F Fändrich
Mar 22, 2006·Pediatric Research·Juris J MeierPeter C Butler
Mar 29, 2006·Diabetes Care·R Paul RobertsonUNKNOWN American Diabetes Association
Apr 22, 2006·The Journal of Clinical Investigation·Damien BressonMatthias von Herrath
Jul 5, 2006·The Journal of Experimental Medicine·Weihong LiuJeffrey A Bluestone
Aug 4, 2006·Current Opinion in Immunology·Suna Onengut-Gumuscu, Patrick Concannon
Aug 15, 2006·Immunological Reviews·Shimon SakaguchiTakashi Nomura
Aug 15, 2006·Immunological Reviews·Maria Grazia RoncaroloMegan K Levings
Aug 15, 2006·Immunological Reviews·Clare Baecher-Allan, David A Hafler
Sep 29, 2006·The New England Journal of Medicine·A M James ShapiroJonathan R T Lakey
Oct 21, 2006·Nature Biotechnology·Kevin A D'AmourEmmanuel E Baetge
Nov 15, 2006·Diabetes/metabolism Research and Reviews·Nienke van der WerfJan-Luuk Hillebrands

❮ Previous
Next ❯

Citations

Feb 17, 2009·Biogerontology·Jan O Nehlin, Torben Barington
Jan 15, 2013·Cryobiology·Mélanie GrondinDiana A Averill-Bates
Jul 31, 2012·Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS·C A RaduT Kremer
Jul 9, 2009·Journal of Cellular and Molecular Medicine·Abdelkrim HmadchaBernat Soria
Sep 18, 2009·Annals of the New York Academy of Sciences·Martin Joseph Richer, Marc Steven Horwitz
Jun 25, 2008·Transplant International : Official Journal of the European Society for Organ Transplantation·James A HutchinsonFred Fändrich
Oct 29, 2008·Transplant International : Official Journal of the European Society for Organ Transplantation·Gregor WarneckeMartin Strüber
Feb 14, 2009·Diabetes/metabolism Research and Reviews·Evridiki Sgouroudis, Ciriaco A Piccirillo
Mar 6, 2015·Biotechnology Journal·Mélanie GrondinDiana A Averill-Bates
Feb 19, 2016·Protein Science : a Publication of the Protein Society·Mélanie Chow-Shi-YéeFrançois Ouellet
Jul 23, 2020·Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission·Dilşad ÖzerkanÇiğdem Özer
Mar 21, 2009·Current Opinion in Endocrinology, Diabetes, and Obesity

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.